central venous catheter
Jump to navigation
Jump to search
Indications
- hypotension requiring large fluid volume & rapid infusion
- dehydration with no peripheral intravenous access
- administration of pharmaceutical agents & nutrition not possible through peripheral access
- for administration of intravenous antiarrhythmic agents & vasopressors
- measurement of central venous pressure for assessing circulating volume status[5][6]
- management of heart failure
Contraindications
- thrombocytopenia
- increased prothrombin time or partial thromboplastin time
- avoid central venous catheters if possible in patient with chronic renal failure who may eventually need hemodialysis
Benefit/risk
- no difference in risk of catheter-related infection or deep vein thrombosis for femoral catheter vs subclavian catheter
- number needed to harm = 73 for pneumothorax (subclavian catheter)[9]
Caution:
- Never lose sight of the guidewire
- observe for arrhythmias is close to right atrium
- if an attempt on one side in unsuccessful, verify the absence of pneumothorax before attempting other side
Procedure
approaches*
- subclavian vein
- from above & below the clavicle
- complications
- pneumothorax 1-2%
- subclavian artery puncture 1%
- long term access
- measurement of central venous pressure
- elective, real-time, ultrasound-guided cannulation may reduce mechanical complications & insertion time, & improve the overall success rate[12]
- external jugular vein*
- external jugular vein runs at lateral edge of sternocleidomastoid
- eliminates risk of pneumothorax
- bleeding is easily controlled
- major problem is difficulty advancing catheter
- not well tolerated by conscious patients
- may lead to impairment of neck mobility in patients with coagulopathy
- measurement of central venous pressure
- internal jugular vein
- access between bifurcation of sternocleidomastoid
- risk of carotid puncture 2-10%
- need to rule out pneumothorax
- contraindicated if platelets < 50,000/mm3 or if PT is > 3 sec more than control
- measurement of central venous pressure
- a small bore single lumen catheter in the internal jugular less likely to impair venous drainage from the arm than a subclavian catheter[5]
- femoral vein
- access 1-2 cm medial to femoral artery below inguinal ligament
- no risk of pneumothorax
- bleeding easily controlled
- increased risk of infection if left in place more than 3 days
- thrombosis (10%)
- femoral artery puncture 10%
- limits flexion at hip
- location of a femoral venous line can be confirmed with injection of agitated saline during echocardiogram[7]
* the most effective means of preventing complications is ultrasound-guided internal jugular catheterization, with daily assessment for continued need
* 2-dimensional ultrasound helps with vein localization[3]; reduces procedure failure, vessel injury, pneumothorax[5]
Complications
- 3-10% of central venous catheters are associated with major complications[15]
- pneumothorax*
- intravascular catheter-related infection*[10]
- more common with femoral vein & internal jugular vein catheters than subclavian catheters
- central venous catheters inserted under emergency condition at high risk & should be replaced within 48 hours[5]
- deep vein thrombosis* (including pulmonary embolism)
- more common with femoral vein & internal jugular vein catheters than subclavian catheters
- superior vena cava syndrome
- central venous stenosis most commonly occurs from endothelial damage from central venous catheters
- occlusion of the catheter
- when a catheter permits infusion, but blood cannot be aspirated, the most likely cause is early thrombosis of the line
- remove the catheter & replace it with a new one at a different site
- catheters that allow neither infusion or aspiration should also be replaced
- changing a line over a guide wire is not recommended
- dislodgement of catheter[16]
- bleeding
- platelet counts < 50,000/uL prior to placement result in more bleeding[14]
- arrhythmias
- for short-term indications, midline catheters associated with a lower risk of bloodstream infection & occlusion compared with PICC[13]
* pneumothorax can be diagnosed promptly & treated immediately intravascular catheter-related infection or deep-vein thrombosis may be more problematic[10]
* also see Procedure: (above)
Management
- central venous catheters inserted under emergency condition should be replaced within 48 hours[5]
- hospitalized patients with central venous catheter should be assessed daily to determine if the catheter is still needed[5]
- central venous catheters should be removed if fever & positive blood cultures
- see intravascular catheter-related infection
- patients with mild coagulopathy (INR > 1.5) do not need fresh frozen plasma or other transfusion prior to procedure[5]
- chlorhexidine dressings at the catheter insertion site reduce catheter-associated infections
- chlorhexidine impregnated sponges
- chlorhexidine-gel dressings allow visualization of the insertion site[4]
Notes
- 20% of clinicians unaware their patient has a central line[8]
- teaching physicians & hospitalist more likely to be unaware of central line than interns, residents, nurse practitioners, & physician assistants (27% vs 16%)[8]
More general terms
More specific terms
- central venous catheter with subcutaneous port
- dialysis vascular catheter
- midline catheter
- peripherally-inserted central catheter (PICC)
Additional terms
References
- ↑ Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 246-48
- ↑ Journal Watch 21(18):144, 2001
Merrer J, De Jonghe B, Golliot F et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001 Aug 10; 286:700. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11495620 - ↑ 3.0 3.1 Journal Watch 23(20):163, 2003
Hind D, Calvert N, McWilliams R et al Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ. 2003 Aug 16;327(7411):361. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12919984 Free PMC Article <Internet> http://bmj.bmjjournals.com/cgi/content/full/327/7411/361 - ↑ 4.0 4.1 Timsit J-F et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 2012 Dec 15; 186:1272. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23043083
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18, 19. American College of Physicians, Philadelphia 2012, 2015, 2018, 2021.
- ↑ 6.0 6.1 6.2 Hoggard J, Saad T, Schon D et al Guidelines for venous access in patients with chronic kidney disease. A Position Statement from the American Society of Diagnostic and Interventional Nephrology, Clinical Practice Committee and the Association for Vascular Access. Semin Dial. 2008 Mar-Apr;21(2):186-91 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18364015
- ↑ 7.0 7.1 Horowitz R et al. The FLUSH study - Flush the Line and Ultrasound the Heart: Ultrasonographic confirmation of central femoral venous line placement. Ann Emerg Med 2014 Jan 17 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24439714
- ↑ 8.0 8.1 8.2 Chopra V et al Do Clinicians Know Which of Their Patients Have Central Venous Catheters?: A Multicenter Observational Study. Ann Intern Med. 2014;161(8):562-567 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25329204 <Internet> http://annals.org/article.aspx?articleid=1916822
Taichman DB Whose Line Is It Anyway? Ann Intern Med. 2014;161(8):607-608 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25329208 <Internet> http://annals.org/article.aspx?articleid=1916831 - ↑ 9.0 9.1 The NNT: Subclavian vs. Femoral Central Line Placement. http://www.thennt.com/nnt/subclavian-vs-femoral-central-line-placement/
Hamilton HC, Foxcroft DR. Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004084. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17636746 - ↑ 10.0 10.1 10.2 Parienti JJ et al Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med 2015; 373:1220-1229. September 24, 2015. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26398070 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1500964
- ↑ McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003 Mar 21; 348:1123 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12646670 Free full text <Internet> http://www.nejm.org/doi/full/10.1056/NEJMra011883
- ↑ 12.0 12.1 Schulman PM, Gerstein NS, Merkel MJ et al Ultrasound-Guided Cannulation of the Subclavian Vein. N Engl J Med 2018; 379:e1. July 5, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29972747 https://www.nejm.org/doi/full/10.1056/NEJMvcm1406114
- ↑ 13.0 13.1 Swaminathan L, Flanders S, Horowitz J et al. Safety and outcomes of midline catheters vs peripherally inserted central catheters for patients with short-term indications: A multicenter study. JAMA Intern Med 2022 Jan; 182:50-58. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34842905 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2786212
- ↑ 14.0 14.1 van Baarle FLF et al. Platelet transfusion before CVC placement in patients with thrombocytopenia. N Engl J Med 2023 May 25; 388:1956. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37224197 https://www.nejm.org/doi/10.1056/NEJMoa2214322
- ↑ 15.0 15.1 Teja B et al. Complication rates of central venous catheters: A systematic review and meta-analysis. JAMA Intern Med 2024 Mar 4; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38436976 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2815818
- ↑ 16.0 16.1 Corley A, Royle RH, Marsh N et al. Incidence and risk factors for central venous access device failure in hospitalized adults: A multivariable analysis of 1892 catheters. J Hosp Med 2024 Oct; 19:905 PMID: https://www.ncbi.nlm.nih.gov/pubmed/38800854 https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.13414